Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsrheumatology-musculoskeletal-and-sports

Paeds SAQs · rheumatology-musculoskeletal-and-sports

Performance-enhancing substances in young athletes — formative SAQs

Formative SAQs on performance-enhancing substances in the young athlete: the WADA prohibited list and strict liability, the physical signs and confidential history that reveal anabolic-androgenic steroid use, the cardiovascular growth and psychiatric harms including the suicidal withdrawal, and the counselling-first management with the ATLAS prevention model.

20 marks30 min4 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Performance-enhancing substance use in the young athlete

SAQ 1 — The boy who gained nine kilograms (10 marks)

Stem: A fifteen-year-old boy presents with a sore shoulder. Alone in the consultation, he discloses that he has gained nine kilograms of lean mass over a term and has been injecting testosterone and an oral steroid bought online for four months. On examination he has severe cystic acne over his back and shoulders, gynaecomastia, and small testes for his pubertal stage. [6] [1]

a) Name the most likely class of substance and explain why the aromatisation of excess androgen is of specific concern in this adolescent. (2 marks) [4] [6]

b) List the physical stigmata that support the diagnosis and the baseline investigations you would arrange to quantify the harm. (3 marks) [6]

c) Explain why the cessation of androgens must be slow and supported, and what psychiatric risk an abrupt withdrawal carries. (3 marks) [4] [6]

d) Outline the five steps of the counselling pathway and the prevention evidence you would cite to the family. (2 marks) [5] [6]


Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics, 2006.PMID 16510635
  2. [4]Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 2014.PMID 24582699
  3. [5]Goldberg L, Elliot D, Clarke GN, MacKinnon DP, Moe E, et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA, 1996.PMID 8918852
  4. [6]Mulcahey MK, Schiller JR, Hulstyn MJ. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. The Physician and Sportsmedicine, 2010.PMID 20959703
  5. [9]Kozhuharov VR, Ivanov K, Ivanova S. Dietary Supplements as Source of Unintentional Doping. BioMed Research International, 2022.PMID 35496041
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPain amplification, juvenile fibromyalgia and complex regional pain syndrome: SAQrheumatology-musculoskeletal-and-sportsNextPeriodic fever and autoinflammatory syndromes — formative SAQsrheumatology-musculoskeletal-and-sports